The upregulation of Cxcl1,2 by cancer cells in response to gemcitabine treatment was further confirmed in flow cytometry sorted disseminated pancreatic cancer cells (figure 7B). The gene discussed is CXCL1; the disease is familial pancreatic carcinoma.